SI1163207T1 - An improved process for the preparation of non-hygroscopic salts of l(-)-carnitine - Google Patents

An improved process for the preparation of non-hygroscopic salts of l(-)-carnitine

Info

Publication number
SI1163207T1
SI1163207T1 SI200030176T SI200030176T SI1163207T1 SI 1163207 T1 SI1163207 T1 SI 1163207T1 SI 200030176 T SI200030176 T SI 200030176T SI 200030176 T SI200030176 T SI 200030176T SI 1163207 T1 SI1163207 T1 SI 1163207T1
Authority
SI
Slovenia
Prior art keywords
carnitine
preparation
improved process
hygroscopic salts
hygroscopic
Prior art date
Application number
SI200030176T
Other languages
English (en)
Slovenian (sl)
Inventor
Claudio Cavazza
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of SI1163207T1 publication Critical patent/SI1163207T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200030176T 1999-03-19 2000-03-16 An improved process for the preparation of non-hygroscopic salts of l(-)-carnitine SI1163207T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999MI000551A IT1312018B1 (it) 1999-03-19 1999-03-19 Procedimento migliorato per la produzione di sali non igroscopicidella l(-)-carnitina.
EP00920506A EP1163207B1 (de) 1999-03-19 2000-03-16 Verfahren zur herstellung nicht-hygroscopische l (-) - carnitine salze
PCT/EP2000/002344 WO2000056701A1 (en) 1999-03-19 2000-03-16 An improved process for the preparation of non-hygroscopic salts of l(-)-carnitine

Publications (1)

Publication Number Publication Date
SI1163207T1 true SI1163207T1 (en) 2003-12-31

Family

ID=11382333

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030176T SI1163207T1 (en) 1999-03-19 2000-03-16 An improved process for the preparation of non-hygroscopic salts of l(-)-carnitine

Country Status (22)

Country Link
US (1) US6372940B1 (de)
EP (1) EP1163207B1 (de)
JP (1) JP2002540094A (de)
KR (1) KR100664560B1 (de)
CN (1) CN1147462C (de)
AR (1) AR023101A1 (de)
AT (1) ATE247627T1 (de)
AU (1) AU4105800A (de)
CA (1) CA2359106A1 (de)
CZ (1) CZ299312B6 (de)
DE (1) DE60004649T2 (de)
DK (1) DK1163207T3 (de)
ES (1) ES2204555T3 (de)
HK (1) HK1042468A1 (de)
HU (1) HUP0200402A3 (de)
IT (1) IT1312018B1 (de)
NZ (1) NZ512640A (de)
PL (1) PL199614B1 (de)
PT (1) PT1163207E (de)
SI (1) SI1163207T1 (de)
SK (1) SK13312001A3 (de)
WO (1) WO2000056701A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2631569B1 (fr) * 1988-05-20 1990-07-27 Renault Automation Detecteur de proximite magnetique destine notamment a la decoupe laser
ITRM20010030A1 (it) * 2001-01-23 2002-07-23 Aldo Fassi Sali di carnitine utili come integratori dietetici/nutrizionali o come farmaci, composizioni che li contengono e procedimenti per la loro pr
EP1953162B9 (de) * 2001-02-24 2012-10-31 Boehringer Ingelheim Pharma GmbH & Co. KG Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (de) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG Zusammensetzungen von DPP-IV-Inhibitoren
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EA030606B1 (ru) 2006-05-04 2018-08-31 Бёрингер Ингельхайм Интернациональ Гмбх Способы приготовления лекарственного средства, содержащего полиморфы
CN101209975B (zh) * 2006-12-29 2010-12-01 沈阳科硕营养科技有限公司 左旋肉碱富马酸钙及其制备方法与用途
EP3542801A1 (de) * 2007-08-17 2019-09-25 Boehringer Ingelheim International GmbH Purinderivate zur verwendung bei der behandlung von fap-bedingten erkrankungen
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
PE20110297A1 (es) * 2008-08-15 2011-05-26 Boehringer Ingelheim Int Inhibidores de dpp-4 para la cicatrizacion de heridas
KR20110067096A (ko) 2008-09-10 2011-06-21 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 및 관련 상태를 치료하기 위한 병용 요법
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
JP2012512848A (ja) 2008-12-23 2012-06-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 有機化合物の塩の形態
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
BR112012012641A2 (pt) 2009-11-27 2020-08-11 Boehringer Ingelheim International Gmbh TRATAMENTO DE PACIENTES DIABÉTICOS GENOTIPADOS COM INIBIDORES DE DPP-lVTAL COMO LINAGLIPTINA
WO2011138421A1 (en) 2010-05-05 2011-11-10 Boehringer Ingelheim International Gmbh Combination therapy
EP3366304B1 (de) 2010-06-24 2020-05-13 Boehringer Ingelheim International GmbH Diabetestherapie
EP2425834A1 (de) * 2010-09-06 2012-03-07 Lonza Ltd. Verfahren zur Herstellung von L-Carnitin-Tartrat
JP2012092036A (ja) * 2010-10-26 2012-05-17 Mitsubishi Rayon Co Ltd カルニチンの塩の製造方法
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
WO2013010964A1 (en) 2011-07-15 2013-01-24 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US20140316156A1 (en) * 2013-04-18 2014-10-23 Deborah Warner Method of producing therapeutic agent
ES2950384T3 (es) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Uso médico de un inhibidor de DPP-4
EP3468562A1 (de) 2016-06-10 2019-04-17 Boehringer Ingelheim International GmbH Kombinationen aus linagliptin und metformin
CN106748845B (zh) * 2016-12-23 2018-11-20 东北制药集团股份有限公司 一种左旋肉碱盐微粉的制备方法
KR20190017310A (ko) 2017-08-10 2019-02-20 주식회사 셀트리온화학연구소 약제학적 성질이 개선된 l-카르니틴 화합물의 염, 이의 제조방법, 이를 함유하는 약학 조성물
JP6964876B2 (ja) * 2017-11-27 2021-11-10 株式会社古川リサーチオフィス オロット酸−カルニチン混合体粉体又はフマル酸−カルニチン混合体粉体の製造方法
CN108383741A (zh) * 2018-03-16 2018-08-10 开原亨泰化工有限公司 一种制备左旋肉碱成盐的新方法
CN109096129B (zh) * 2018-09-30 2021-04-27 东北制药集团股份有限公司 一种左旋肉碱酒石酸盐的制备方法
CN109535022B (zh) * 2018-11-12 2022-03-01 天津大学 一种提高左旋肉碱富马酸盐流动性的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0150688B1 (de) * 1983-12-28 1987-04-22 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Salze von L-Carnitin und Alkanoyl-L-Carnitinen sowie Verfahren zur Herstellung derselben
US5073376A (en) * 1989-12-22 1991-12-17 Lonza Ltd. Preparations containing l-carnitine
IT1289974B1 (it) * 1997-02-25 1998-10-19 Aldo Fassi Procedimento per la produzione di sali stabili e non igroscopici di l(-)carnitina e di alcanoli l(-)-carnitine
PL188558B1 (pl) * 1996-05-31 2005-02-28 Sigma Tau Ind Farmaceuti Sole L(-)karnityny i alkanoilo L(-)karnityn, sposób ich wytwarzania i kompozycje farmaceutyczne zawierające takie sole

Also Published As

Publication number Publication date
CN1147462C (zh) 2004-04-28
CZ299312B6 (cs) 2008-06-18
HUP0200402A3 (en) 2002-11-28
NZ512640A (en) 2003-03-28
HK1042468A1 (zh) 2002-08-16
DE60004649T2 (de) 2004-03-18
HUP0200402A2 (hu) 2002-05-29
CN1339023A (zh) 2002-03-06
KR100664560B1 (ko) 2007-01-03
ATE247627T1 (de) 2003-09-15
EP1163207A1 (de) 2001-12-19
US6372940B1 (en) 2002-04-16
KR20010102288A (ko) 2001-11-15
EP1163207B1 (de) 2003-08-20
ES2204555T3 (es) 2004-05-01
CA2359106A1 (en) 2000-09-28
AU4105800A (en) 2000-10-09
CZ20013376A3 (cs) 2002-02-13
DE60004649D1 (de) 2003-09-25
AR023101A1 (es) 2002-09-04
SK13312001A3 (sk) 2002-05-09
WO2000056701A1 (en) 2000-09-28
ITMI990551A1 (it) 2000-09-19
JP2002540094A (ja) 2002-11-26
IT1312018B1 (it) 2002-04-04
PL199614B1 (pl) 2008-10-31
PT1163207E (pt) 2003-12-31
PL349894A1 (en) 2002-09-23
DK1163207T3 (da) 2003-12-01

Similar Documents

Publication Publication Date Title
HUP0200402A3 (en) An improved process for the preparation of non-hygroscopic salts of l(-)-carnitine
HUP0300592A3 (en) Process for the preparation of 2-halobenzoic acid derivatives
HUP0100215A3 (en) Process for the preparation of substantially amorphous alpha-ol
IL146579A0 (en) Process for the preparation of herbicidal derivatives
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
HUP0001674A3 (en) Process for the preparation of stable, non-hygroscopic salts of l(-)carnitine
HUP0302594A3 (en) Process for the preparation of phenethylamine derivatives
IL131644A0 (en) Process for the preparation of nicotinic acid
HUP0103788A3 (en) Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives
EP1176150A4 (de) Ein verfahren zur herstellung von trifluorothymidin-derivaten
GB2363605B (en) Process for the preparation of alpha-aminoketone derivatives
IL153424A0 (en) Process for the preparation of quinoline derivatives
AU8824201A (en) Process for the preparation of dinapsoline
IL150245A0 (en) Process for the preparation of sodium salts of statins
HUP0202865A3 (en) Process for the preparation of 2-cyanopyridines
IL138691A (en) Process for the preparation of 3-acyl-indoles
EP1142898A4 (de) Verfahren zur herstellung von phosphonitverbindungen
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
IL142218A0 (en) PROCESS FOR THE PREPARATION OF (-) -α- DIFLUORMETHYLORNITHINE MONOHYDROCHLORIDE MONOHYDRATE
HUP0000982A3 (en) Process for the preparation of 1,1-dioxo-penicillanic acid derivatives
HRP20020098A2 (en) Process for the preparation of isotretinoin
HU9904575D0 (en) Process for preparation of n-alkoxy-methyl-acidamides
GB0012249D0 (en) Process for the preparation of 11-oxaprostaglandins
PL352099A1 (en) Process for the preparation of tetrafluorohalogenbenzenes
SI1283845T1 (en) Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine